Clean Science has recently informed exchanges that its subsidiary, Clean Fino-Chem Limited (CFCL), has officially begun the commercial production of Butylated Hydroxy Toluene (BHT) on December 16, 2024.
“We wish to inform you that, Clean Fino-Chem Limited (“CFCL”), Wholly Owned Subsidiary of the Company has commenced commercial production of Butylated Hydroxy Toluene (BHT) on campaign basis from yesterday i.e., 16th December, 2024 at Plot No. D-2 MIDC Kurkumbh, Taluka Daund, Dist- Pune – 413802,” the company shared on exchanges.
This new addition complements CFCL’s existing portfolio of antioxidants, including Butylated Hydroxy Anisole (BHA), Tertiary Butyl Hydroquinone (TBHQ), and Ascorbyl Palmitate (AP), further solidifying its position in the antioxidant supply chain.
CFCL will manufacture BHT on a campaign basis, utilizing its existing production facilities. This move optimizes asset utilization and allows the company to expand its presence in the market, offering a comprehensive range of high-quality antioxidant solutions to meet growing demand.
In the meantime, today as of 11:07 AM, Clean Science shares opened at ₹1,434.00, reaching a high of ₹1,449.90 and a low of ₹1,412.00. The stock has a 52-week high of ₹1,690.00 and a 52-week low of ₹1,243.00.
